Your browser doesn't support javascript.
loading
Folate receptor targeted alpha-therapy using terbium-149.
Müller, Cristina; Reber, Josefine; Haller, Stephanie; Dorrer, Holger; Köster, Ulli; Johnston, Karl; Zhernosekov, Konstantin; Türler, Andreas; Schibli, Roger.
Affiliation
  • Müller C; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland. cristina.mueller@psi.ch.
  • Reber J; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland. josefine.reber@gmail.com.
  • Haller S; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland. stephanie.haller@psi.ch.
  • Dorrer H; Laboratory of Radiochemistry and Environmental Chemistry, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland. holger.dorrer@psi.ch.
  • Köster U; Institut Laue-Langevin, 38000 Grenoble, France. koester@ill.fr.
  • Johnston K; Physics Department, ISOLDE/CERN, 1211 Geneva, Switzerland. karl.johnston@cern.ch.
  • Zhernosekov K; Laboratory of Radiochemistry and Environmental Chemistry, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland. konstantin.zhernosekov@gmail.com.
  • Türler A; Laboratory of Radiochemistry and Environmental Chemistry, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland. andreas.tuerler@psi.ch.
  • Schibli R; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland. roger.schibli@psi.ch.
Pharmaceuticals (Basel) ; 7(3): 353-65, 2014 Mar 13.
Article in En | MEDLINE | ID: mdl-24633429